Exosome Therapeutics Market Analysis

The exosome therapeutics market is estimated to be valued at USD 228.9 Mn in 2024 and is expected to reach USD 1,483.30 Mn by 2031, growing at a compound annual growth rate (CAGR) of 30.6% from 2024 to 2031.

The exosome therapeutics market is expected to witness significant growth due to rising focus of key players on exosome-based therapies and diagnostics. Exosomes have emerged as a promising vehicle for drug delivery due to their nano-sized structure and ability to fuse with the cell membrane. Technological advancements have enabled higher purification and characterization of exosomes, thus helping drug developers to effectively load candidate molecules. In addition, exosome isolation techniques are rapidly improving with ultrafiltration and polymer-based precipitation being widely adopted methods. This has streamlined the manufacturing process and positively impacted the scalability of exosome production. Rising R&D investments by biopharma companies and new product launches are further expected to drive the market during the forecast period.